Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine PK in Gastrectomy Patients
NCT00871273Phase 4Terminated
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Nov 2009
- Primary completion
- Oct 2013
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of capecitabine in gastric adenocarcinoma, sponsored by Cambridge University Hospitals NHS Foundation Trust. Started Nov 2009; status: terminated.
02
Drugs
capecitabine
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT00871273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00871273.